1-7 of 7
Takeaki Sugawara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Factors Relating to the Favorable Outcome in Reduced-Dose R-CHOP Therapy for Elderly DLBCL Patients

Keiko Ono, MD, Hideki Tsujimura, MD PhD, Satoshi Maruyama, MD, Akiyasu Satou, MD, Takeaki Sugawara, MD PhD, Kyoya Kumagai, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4241.
https://doi.org/10.1182/blood-2018-99-110699
Published: 2018
Journal Articles

Optimal Treatment Strategy with Nilotinib for Patients with Newly Diagnosed Chronic Myelogenous Leukemia in the Chronic Phase Based on Early Achievement of Deep Molecular Response (MR 4.5 ) : First Report from N-Road, a Phase II Study in Japan

Kaichi Nishiwaki, MD PhD, Kei-Ji Sugimoto, MD PhD, Shigehisa Tamaki, MD PhD, Junichi Hisatake, MD PhD, Hisayuki Yokoyama, MD PhD, Tadahiko Igarashi, MD PhD, Atsushi Shinagawa, MD PhD, Takeaki Sugawara, MD PhD, Satoru Hara, MD PhD, Kazuhisa Fujikawa, MD PhD, Seiichi Shimizu, MD PhD, Yujiri Toshiaki, MD PhD, Arinobu Tojo, MD PhD, Hisashi Wakita, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1925.
https://doi.org/10.1182/blood.V128.22.1925.1925
Published: 2016
Journal Articles

Retrospective Study of the Optimal CHOP Dose for Elderly Patients with Diffuse Large B-Cell Lymphoma

Keiko Ono, MD, Hideki Tsujimura, MD, Akiyasu Satou, MD, Xiaofei Wang, MD PhD, Takeaki Sugawara, MD PhD, Mikiko Ise, MD PhD, Kyoya Kumagai, MD
Journal: Blood
Blood (2016) 128 (22): 4211.
https://doi.org/10.1182/blood.V128.22.4211.4211
Published: 2016
Journal Articles

Twice-Weekly Trimethoprim-Sulfamethoxazole for the Prevention of Pneumocystis Jiroveci Pneumonia in Non-Hodgkin Lymphoma Patients

Keiko Ono, MD, Hideki Tsujimura, Takeaki Sugawara, MD PhD, Mikiko Ise, MD PhD, Akiyasu Satou, MD, Xiaofei Wang, MD PhD, Kyoya Kumagai, MD
Journal: Blood
Blood (2015) 126 (23): 5093.
https://doi.org/10.1182/blood.V126.23.5093.5093
Published: 2015
Journal Articles

Impact of Serum Soluble LR11 on Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Multicenter Prospective Study

Yasumasa Sugita, MD, Chikako Ohwada, MD PhD, Takeharu Kawaguchi, MD PhD, Tomoya Muto, MD PhD, Shokichi Tsukamoto, MD PhD, Yusuke Takeda, MD PhD, Naoya Mimura, MD PhD, Masahiro Takeuchi, MD PhD, Emiko Sakaida, MD PhD, Naomi Shimizu, MD PhD, Hiroaki Tanaka, MD, PhD, Daijiro Abe, MD, PhD, Motoharu Fukazawa, MD PhD, Takeaki Sugawara, MD PhD, Nobuyuki Aotsuka, MD PhD, Kaichi Nishiwaki, MD PhD, Akira Yokota, MD PhD, Hiroyuki Ebinuma, PhD, Kengo Fujimura, PhD, Hideaki Bujo, MD PhD, Chiaki Nakaseko, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1661.
https://doi.org/10.1182/blood.V124.21.1661.1661
Published: 2014
Journal Articles

TET Family Oncogene Fus Is Essential for the Maintenance of Self-Renewing Hematopoietic Stem Cells.

Takeaki Sugawara, MD, PhD, Hideyuki Oguro, PhD, Atsushi Iwama, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2529.
https://doi.org/10.1182/blood.V114.22.2529.2529
Published: 2009
Journal Articles

Impaired Repopulating Activity of Fus-Deficient Hematopoietic Stem Cells.

Takeaki Sugawara, Atsushi Iwama
Journal: Blood
Blood (2007) 110 (11): 2222.
https://doi.org/10.1182/blood.V110.11.2222.2222
Published: 2007